[
  {
    "ts": null,
    "headline": "AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript",
    "summary": "AbbVie Inc. (ABBV) Piper Sandler 37th Annual Healthcare Conference December 3, 2025 8:30 AM ESTCompany ParticipantsDavid Amsellem - MD & Senior Research...",
    "url": "https://finnhub.io/api/news?id=c355bc231ba418d02e413324edd3d1e1c38c957b67887a8a9ebd8f27c819711b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764780808,
      "headline": "AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript",
      "id": 137674359,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "AbbVie Inc. (ABBV) Piper Sandler 37th Annual Healthcare Conference December 3, 2025 8:30 AM ESTCompany ParticipantsDavid Amsellem - MD & Senior Research...",
      "url": "https://finnhub.io/api/news?id=c355bc231ba418d02e413324edd3d1e1c38c957b67887a8a9ebd8f27c819711b"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=dd51209c4b5006313cdb4a2dd2350194e2adf9372fd6a6c3d57a68669dae6478",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764779460,
      "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "id": 137681612,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=dd51209c4b5006313cdb4a2dd2350194e2adf9372fd6a6c3d57a68669dae6478"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=7767d33c9ccd1d78e5455da19b7c747e14540a1d12a914b956570f25edc737c1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764770406,
      "headline": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know",
      "id": 137671019,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=7767d33c9ccd1d78e5455da19b7c747e14540a1d12a914b956570f25edc737c1"
    }
  },
  {
    "ts": null,
    "headline": "Is It Too Late to Consider AbbVie After Its Strong Multi Year Share Price Rally?",
    "summary": "If you are wondering whether AbbVie is still attractive after its huge run, or if you are late to the party, you are in the right place to unpack what the current share price really implies. Even after a strong long-term climb, with the stock up 27.9% over the last year and 153.2% over five years, recent returns have cooled a bit, with a 3.2% dip in the last week but still a 2.9% gain over the past month and 25.0% year to date. Investors have been reacting to ongoing developments around...",
    "url": "https://finnhub.io/api/news?id=86a311f4f02867abc57d448dd6c00c3f42143cdb40383424764e1b28a67e8eeb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764724246,
      "headline": "Is It Too Late to Consider AbbVie After Its Strong Multi Year Share Price Rally?",
      "id": 137667634,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "If you are wondering whether AbbVie is still attractive after its huge run, or if you are late to the party, you are in the right place to unpack what the current share price really implies. Even after a strong long-term climb, with the stock up 27.9% over the last year and 153.2% over five years, recent returns have cooled a bit, with a 3.2% dip in the last week but still a 2.9% gain over the past month and 25.0% year to date. Investors have been reacting to ongoing developments around...",
      "url": "https://finnhub.io/api/news?id=86a311f4f02867abc57d448dd6c00c3f42143cdb40383424764e1b28a67e8eeb"
    }
  }
]